Dexcom Inc
Dexcom Inc (DXCM) is showing strong potential with a current price of $65.8, reflecting a 4.26% increase from the previous close of $63.11. The company's revenue growth year-over-year stands at 15.60%, while EPS growth is an impressive 47.91%. With a market cap of $25.32B and a robust return on equity (ROE) of 32.44%, DXCM is positioned favorably within the healthcare sector, especially given its strong analyst ratings with 15 Strong Buy recommendations.
Buy DXCM stock for long-term growth as it continues to demonstrate strong fundamentals and market potential.
DexCom Inc. stock outperforms competitors on strong trading day
2026-04-06
Is DexCom (DXCM) Fairly Priced After Recent Share Price Weakness?
2026-04-03
Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time
2026-04-02
2 Growth Stocks with All-Star Potential and 1 That Underwhelm
2026-04-01